{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T12:33:25Z","timestamp":1789216405934,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2-3","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["neurotox res"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1007\/bf03354881","type":"journal-article","created":{"date-parts":[[2015,6,23]],"date-time":"2015-06-23T08:21:16Z","timestamp":1435047676000},"page":"101-107","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Re-engineering the target specificity of clostridial neurotoxins - a route to novel therapeutics"],"prefix":"10.1007","volume":"9","author":[{"given":"Keith A.","family":"Foster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily J.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyndsey","family":"Durose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline J.","family":"Cruttwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford C.","family":"Shone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Chaddock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare L.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Heaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Mark","family":"Sutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Wayne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances C. G.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duncan F.","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,5,7]]},"reference":[{"key":"BF03354881_CR1","first-page":"427","volume-title":"Bacterial Protein Toxins","author":"B. Bizzini","year":"1984","unstructured":"Bizzini B (1984) Investigation of the mode of action of tetanus toxin with the aid of hybrid molecules consisting in part of tetanus toxin-derived fragments, In: Bacterial Protein Toxins (Alouf JE, Ed.) (Academic Press: London, UK), pp 427\u2013434."},{"key":"BF03354881_CR2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0092-8674(03)01079-1","volume":"116","author":"J.S. Bonifacino","year":"2004","unstructured":"Bonifacino JS and BS Glick (2004) The mechanisms of vesicle budding and fusion. Cell 116, 153\u2013166.","journal-title":"Cell"},{"key":"BF03354881_CR3","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1128\/IAI.68.5.2587-2593.2000","volume":"68","author":"J.A. Chaddock","year":"2000","unstructured":"Chaddock JA, JR Purkiss, LM Friis, JD Broadbridge, MJ Duggan, SJ Fooks, CC Shone, CP Quinn and KA Foster (2000a) Inhibition of vesicular secretion in both neuronal and non-neuronal cells by a retargeted endopeptidase derivative of Clostridium botulinum neurotoxin type A. Infect. & Immunol. 68, 2587\u20132593.","journal-title":"Infect. & Immunol."},{"key":"BF03354881_CR4","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/08977190009003240","volume":"18","author":"J.A. Chaddock","year":"2000","unstructured":"Chaddock JA, JR Purkiss, MJ Duggan, CP Quinn, CC Shone and KA Foster (2000b) A conjugate composed of nerve growth factor coupled to a non-toxic derivative of Clostridium botulinum neurotoxin type A can inhibit neurotransmitter release in vitro. Growth Factors 18, 147\u2013155.","journal-title":"Growth Factors"},{"key":"BF03354881_CR5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1046-5928(02)00002-5","volume":"25","author":"J.A. Chaddock","year":"2002","unstructured":"Chaddock, JA, MH Herbert, RJ Ling, FCG Alexander, SJ Fooks, DF Revell, CP Quinn, CC Shone and KA Foster (2002) Expression and purification of catalytically active, non-toxic endopeptidase derivatives of Clostridium botulinum toxin type A. Protein Expr. Purif. 25, 219\u2013228.","journal-title":"Protein Expr. Purif."},{"issue":"S8","key":"BF03354881_CR6","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1002\/mds.20008","volume":"19","author":"J.A. Chaddock","year":"2004","unstructured":"Chaddock JA, MJ Duggan, CP Quinn, JR Purkiss, FCG Alexander, S Doward, SJ Fooks, L Friis, Y Hall, ER Kirby, NJ Leeds, HJ Moulsdale, A Dickenson, GM Green, W Rahman, R Suzuki, CC Shone and KA Foster (2004) Retargeted clostridial endopeptidases: inhibition of nociceptive neurotransmitter release in vitro, and antinociceptive activity in in vivo models of pain. Mov. Disord. 19(S8), S42\u2013S47.","journal-title":"Mov. Disord."},{"issue":"S8","key":"BF03354881_CR7","doi-asserted-by":"crossref","first-page":"S157","DOI":"10.1002\/mds.20071","volume":"19","author":"C. Cordivari","year":"2004","unstructured":"Cordivari C, VP Misra, S Catania and AJ Lees (2004) New therapeutic indications for botulinum toxins. Mov. Disord. 19(S8), S157\u2013S161.","journal-title":"Mov. Disord."},{"issue":"38","key":"BF03354881_CR8","doi-asserted-by":"crossref","first-page":"34846","DOI":"10.1074\/jbc.M202902200","volume":"277","author":"M.J. Duggan","year":"2002","unstructured":"Duggan MJ, CP Quinn, JA Chaddock, JR Purkiss, FCG Alexander, S Doward, SJ Fooks, L Friis, Y Hall, ER Kirby, NJ Leeds, HJ Moulsdale, A Dickenson, GM Green, W Rahman, R Suzuki, CC Shone and KA Foster (2002) Inhibition of release of neurotransmitters from rat dorsal root ganglia by a novel conjugate of a Clostridium botulinum toxin A endopeptidase fragment and Erythrina cristagalli lectin. J. Biol. Chem. 277(38), 34846\u201334852.","journal-title":"J. Biol. Chem."},{"key":"BF03354881_CR9","doi-asserted-by":"crossref","first-page":"11188","DOI":"10.1016\/S0021-9258(18)82109-3","volume":"268","author":"J.L. Halpern","year":"1993","unstructured":"Halpern JL and A Loftus (1993) Characterisation of the receptor binding domain of tetanus toxin. J. Biol. Chem. 268, 11188\u201311192.","journal-title":"J. Biol. Chem."},{"key":"BF03354881_CR10","first-page":"11","volume-title":"Scientific and Therapeutic Aspects of Botulinum Toxin","author":"M.A. Hanson","year":"2002","unstructured":"Hanson MA and RC Stevens (2002) Structural view of botulinum neurotoxin in numerous functional states, In: Scientific and Therapeutic Aspects of Botulinum Toxin (Brin MF, J Jankovic and M Hallett, Eds.) (Lippincott Williams & Wilkins: Philadelphia, PA, USA), pp 11\u201328."},{"key":"BF03354881_CR11","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0021-9258(17)32814-4","volume":"252","author":"T.B. Helting","year":"1977","unstructured":"Helting TB and O Zwisler (1977) Structure of tetanus toxin. J. Biol. Chem. 252, 187\u2013193.","journal-title":"J. Biol. Chem."},{"key":"BF03354881_CR12","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1046\/j.1471-4159.2000.0741941.x","volume":"74","author":"J. Herreros","year":"2000","unstructured":"Herreros J, G Lalli, C Montecucco, and G Schiavo (2000) Tetanus toxin fragment C binds to a protein present in neuronal cell lines and motorneurons. J. Neurochem. 74, 1941\u20131950.","journal-title":"J. Neurochem."},{"key":"BF03354881_CR13","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0300-9084(00)00216-9","volume":"82","author":"Y. Humeau","year":"2000","unstructured":"Humeau Y, F Doussau, NJ Grant and B Poulain (2000) How botulinum and tetanus neurotoxins block neurotransmitter release. Biochimie 82, 427\u2013446.","journal-title":"Biochimie"},{"key":"BF03354881_CR14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nsb879","volume":"10","author":"L.K. Koriazova","year":"2003","unstructured":"Koriazova LK and M Montal (2003) Translocation of botulinum neurotoxin light chain protease through the heavy chain channel. Nat. Struct. Biol. 10, 13\u201318.","journal-title":"Nat. Struct. Biol."},{"key":"BF03354881_CR15","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/2338","volume":"5","author":"D.B. Lacy","year":"1998","unstructured":"Lacy DB, W Tepp, AC Cohen, BR DasGupta and RC Stevens (1998) Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nat. Struct. Biol. 5, 898\u2013902.","journal-title":"Nat. Struct. Biol."},{"issue":"Suppl.1","key":"BF03354881_CR16","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1053\/apmr.2003.50121","volume":"84","author":"A.M. Lang","year":"2003","unstructured":"Lang AM (2003) Botulinum toxin type A therapy in chronic pain disorders. Arch. Phys. Med. Rehabil. 84 (Suppl. 1), S69\u2013S73.","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"BF03354881_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2958.1994.tb00396.x","volume":"13","author":"C. Montecucco","year":"1994","unstructured":"Montecucco C and G Schiavo (1994) Mechanism of action of tetanus and botulinum neurotoxins. Mol. Microbiol. 13, 1\u20138.","journal-title":"Mol. Microbiol."},{"key":"BF03354881_CR18","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.coph.2004.01.011","volume":"4","author":"D.F. Rogers","year":"2004","unstructured":"Rogers DF (2004) Airway mucus hypersecretion in asthma: an undervalued pathology? Curr. Opin. Pharmacol. 4, 241\u2013250.","journal-title":"Curr. Opin. Pharmacol."},{"key":"BF03354881_CR19","volume-title":"J. Chron. Obstructive Dis.","author":"D.F. Rogers","year":"2005","unstructured":"Rogers DF (2005) The role of airway secretions in COPD: pathophysiology, epidemiology and pharmacotherapeutic options. J. Chron. Obstructive Dis. 3 (in press)."},{"key":"BF03354881_CR20","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1432-1033.1985.tb09070.x","volume":"151","author":"C.C. Shone","year":"1985","unstructured":"Shone CC, P Hambleton and J Melling (1985) Inactivation of Clostridium botulinum type A neurotoxin by trypsin and purification of two tryptic fragments. Proteolytic action near the COOH-terminus of the heavy subunit destroys toxin-binding activity. Eur. J. Biochem. 151, 75\u201382.","journal-title":"Eur. J. Biochem."},{"key":"BF03354881_CR21","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1432-1033.1987.tb13320.x","volume":"167","author":"C.C. Shone","year":"1987","unstructured":"Shone CC, P Hambleton and J Melling (1987) A 50-kDa fragment from the NH2-terminus of the heavy subunit of Clostridium botulinum type A neurotoxin forms channels in lipid vesicles. Eur. J. Biochem. 167, 175\u2013180.","journal-title":"Eur. J. Biochem."},{"key":"BF03354881_CR22","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1146\/annurev.pa.26.040186.002235","volume":"26","author":"L.L. Simpson","year":"1986","unstructured":"Simpson LL (1986) Molecular pharmacology of botulinum toxin and tetanus toxin. Annu. Rev. Pharmacol. Toxicol. 26, 427\u2013453.","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"BF03354881_CR23","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1177\/33.10.4045182","volume":"33","author":"W.J. Streit","year":"1985","unstructured":"Streit WJ, BA Schulte, DJ Balentine and SS Spicer (1985) Histochemical localization of galactose-containing glycoconjugates in sensory neurons and their processes in the central and peripheral nervous system of the rat. J. Histochem. Cytochem. 33, 1042\u20131052.","journal-title":"J. Histochem. Cytochem."},{"key":"BF03354881_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(86)91185-6","volume":"377","author":"W.J. Streit","year":"1986","unstructured":"Streit WJ, BA Schulte, DJ Balentine and SS Spicer (1986) Evidence for glyco conjugate in nociceptive primary sensory neurons and its origin from the Golgi complex. Brain Res. 377, 1\u201317.","journal-title":"Brain Res."},{"issue":"1","key":"BF03354881_CR25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.pep.2004.06.023","volume":"40","author":"J.M. Sutton","year":"2005","unstructured":"Sutton JM, J Wayne, A Scott-Tucker, SM O'Brien, PMH Marks, FCG Alexander, CC Shone and JA Chaddock (2005) Preparation of specifically activatable endopeptidase derivatives of Clostridium botulinum toxins type A, B and C and their applications. Protein Expr. Purif. 40(1), 31\u201341.","journal-title":"Protein Expr. Purif."},{"key":"BF03354881_CR26","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/78005","volume":"7","author":"S. Swaminathan","year":"2000","unstructured":"Swaminathan S and S Eswaramoorthy (2000) Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B. Nat. Struct. Biol. 7, 693\u2013699.","journal-title":"Nat. Struct. Biol."},{"key":"BF03354881_CR27","first-page":"29","volume-title":"Scientific and Therapeutic Aspects of Botulinum Toxin","author":"S. Swaminathan","year":"2002","unstructured":"Swaminathan S and S Eswaramoorthy (2002) Crystal structure of Clostridium botulinum neurotoxin serotype B, In: Scientific and Therapeutic Aspects of Botulinum Toxin (Brin MF, J Jankovic and M Hallett, Eds.) (Lippincott Williams & Wilkins: Philadelphia, PA, USA), pp 29\u201340."},{"key":"BF03354881_CR28","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/nsb1097-788","volume":"4","author":"T.C. Umland","year":"1997","unstructured":"Umland TC, LM Wingert, S Swaminathan, WF Furey, JJ Schmidt and M Sax (1997) Structure of the receptor binding fragment HC of tetanus toxin. Nat. Struct. Biol. 4, 788\u2013792.","journal-title":"Nat. Struct. Biol."}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03354881.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03354881\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03354881","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T20:23:54Z","timestamp":1652559834000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03354881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":28,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["BF03354881"],"URL":"https:\/\/doi.org\/10.1007\/bf03354881","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}